acetylcysteine has been researched along with Ewing Sarcoma in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Burchill, SA; Magwere, T | 1 |
Figueredo, R; Hanly, L; Koren, G; Koropatnick, J; Rieder, MJ | 1 |
Batra, S; Maurer, BJ; Reynolds, CP | 1 |
Badrinath, Y; Joshi, DS; Mishra, KP; Narkar, AA; Raghuvar Gopal, DV | 1 |
Dritschilo, A; Soldatenkov, VA | 1 |
Choi, YH; Jang, JS | 1 |
6 other study(ies) available for acetylcysteine and Ewing Sarcoma
Article | Year |
---|---|
Heterogeneous role of the glutathione antioxidant system in modulating the response of ESFT to fenretinide in normoxia and hypoxia.
Topics: Acetylcysteine; Antineoplastic Agents; Antioxidants; Apoptosis; Cell Count; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dietary Supplements; Drug Screening Assays, Antitumor; Fenretinide; Gene Knockdown Techniques; Glutathione; Humans; Inhibitory Concentration 50; Intracellular Space; Models, Biological; Reactive Oxygen Species; RNA, Small Interfering; Sarcoma, Ewing | 2011 |
The Effects of N-acetylcysteine on ifosfamide efficacy in a mouse xenograft model.
Topics: Acetylcysteine; Animals; Antineoplastic Agents, Alkylating; Bone Neoplasms; Cell Growth Processes; Cell Line, Tumor; Drug Interactions; Female; Humans; Ifosfamide; Mice; Sarcoma, Ewing; Treatment Outcome; Xenograft Model Antitumor Assays | 2012 |
Fenretinide cytotoxicity for Ewing's sarcoma and primitive neuroectodermal tumor cell lines is decreased by hypoxia and synergistically enhanced by ceramide modulators.
Topics: Acetylcysteine; Antineoplastic Agents; Antioxidants; Apoptosis; Cell Hypoxia; Ceramides; Drug Synergism; Enzyme Inhibitors; Fenretinide; Galactosylgalactosylglucosylceramidase; Gene Expression Profiling; Humans; Membrane Potentials; Mitochondria; Neoplasm, Residual; Neuroectodermal Tumors, Primitive; Oligonucleotide Array Sequence Analysis; Protein Kinase C; Reactive Oxygen Species; Sarcoma, Ewing; Sphingosine; Tumor Cells, Cultured | 2004 |
Protection of Ewing's sarcoma family tumor (ESFT) cell line SK-N-MC from betulinic acid induced apoptosis by alpha-DL-tocopherol.
Topics: Acetylcysteine; alpha-Tocopherol; Annexin A5; Antioxidants; Apoptosis; Ascorbic Acid; Betulinic Acid; Cell Line; Cell Line, Tumor; Cell Survival; Humans; Membrane Potentials; Mitochondria; Pentacyclic Triterpenes; Reactive Oxygen Species; Sarcoma, Ewing; Triterpenes | 2004 |
Apoptosis of Ewing's sarcoma cells is accompanied by accumulation of ubiquitinated proteins.
Topics: Acetylcysteine; Apoptosis; Cysteine Endopeptidases; DNA Fragmentation; Enzyme Inhibitors; Gene Expression; Humans; Multienzyme Complexes; Neoplasm Proteins; Proteasome Endopeptidase Complex; Proto-Oncogene Proteins c-bcl-2; Sarcoma, Ewing; Tumor Cells, Cultured; Ubiquitins | 1997 |
Proteolytic degradation of the retinoblastoma family protein p107: A putative cooperative role of calpain and proteasome.
Topics: Acetylcysteine; Antineoplastic Agents; Blotting, Western; Calcium-Binding Proteins; Calpain; CDC2-CDC28 Kinases; Cell Cycle; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinases; Cysteine Proteinase Inhibitors; Humans; Lovastatin; Male; Nuclear Proteins; Proliferating Cell Nuclear Antigen; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Retinoblastoma Protein; Retinoblastoma-Like Protein p107; Sarcoma, Ewing; Transfection; Tumor Cells, Cultured; Ubiquitins | 1999 |